300 related articles for article (PubMed ID: 8696877)
21. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
Billman GE; Hamlin RL
J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
[TBL] [Abstract][Full Text] [Related]
22. Reduced antiarrhythmic efficacy of verapamil in isolated rat hearts in the presence of elevated extracellular calcium.
Lieu PB; Fornari M; Ramos T; Hatcher AS; Clements-Jewery H
J Cardiovasc Pharmacol; 2011 Apr; 57(4):455-62. PubMed ID: 21283021
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms involved in reperfusion arrhythmias.
Verrier RL; Hagestad EL
Eur Heart J; 1986 May; 7 Suppl A():13-22. PubMed ID: 3522236
[TBL] [Abstract][Full Text] [Related]
24. Is all ventricular fibrillation the same? A comparison of ischemically induced with electrically induced ventricular fibrillation in a porcine cardiac arrest and resuscitation model.
Niemann JT; Rosborough JP; Youngquist S; Thomas J; Lewis RJ
Crit Care Med; 2007 May; 35(5):1356-61. PubMed ID: 17414084
[TBL] [Abstract][Full Text] [Related]
25. Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise.
Muller CA; Opie LH; McCarthy J; Hofmann D; Pineda CA; Peisach M
J Am Coll Cardiol; 1998 Jul; 32(1):268-74. PubMed ID: 9669280
[TBL] [Abstract][Full Text] [Related]
26. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
Nearing BD; Hutter JJ; Verrier RL
J Cardiovasc Pharmacol; 1996 Jun; 27(6):777-87. PubMed ID: 8761843
[TBL] [Abstract][Full Text] [Related]
27. Combination of a calcium antagonist, verapamil, with an angiotensin converting enzyme inhibitor, trandolapril, in experimental myocardial ischemia and reperfusion: antiarrhythmic and hemodynamic effects of chronic oral pretreatment.
Muller CA; Opie LH; Pineda CA; McCarthy J; Kraljevic V
Cardiovasc Drugs Ther; 1998 Oct; 12(5):449-55. PubMed ID: 9926275
[TBL] [Abstract][Full Text] [Related]
28. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation.
Billman GE
J Pharmacol Exp Ther; 1993 Jul; 266(1):407-16. PubMed ID: 8331569
[TBL] [Abstract][Full Text] [Related]
29. Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs.
Andersen HR; Wiggers H; Knudsen LL; Simonsen I; Thomsen PE; Christiansen N
Cardiovasc Res; 1994 Nov; 28(11):1635-40. PubMed ID: 7842456
[TBL] [Abstract][Full Text] [Related]
30. Study of the ventricular antifibrillatory effects of calcium channel blocking agents in comparison with lidocaine on canine normal heart in situ.
Chah QT; Bertrix L; Bouzouita K; Lang J; Faucon G
Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):238-48. PubMed ID: 6838283
[TBL] [Abstract][Full Text] [Related]
31. ATP-sensitive potassium channel blocker HMR 1883 reduces mortality and ischemia-associated electrocardiographic changes in pigs with coronary occlusion.
Wirth KJ; Rosenstein B; Uhde J; Englert HC; Busch AE; Schölkens BA
J Pharmacol Exp Ther; 1999 Nov; 291(2):474-81. PubMed ID: 10525061
[TBL] [Abstract][Full Text] [Related]
32. Effects of verapamil and magnesium sulfate on electrophysiologic changes during acute myocardial ischemia and following reperfusion in dogs: comparative effects of administration by intravenous and coronary sinus retroperfusion routes.
Yamamoto K; Bando S
Angiology; 1996 Jun; 47(6):557-68. PubMed ID: 8678330
[TBL] [Abstract][Full Text] [Related]
33. Novel transient outward and ultra-rapid delayed rectifier current antagonist, AVE0118, protects against ventricular fibrillation induced by myocardial ischemia.
Billman GE; Kukielka M
J Cardiovasc Pharmacol; 2008 Apr; 51(4):352-8. PubMed ID: 18427277
[TBL] [Abstract][Full Text] [Related]
34. [Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].
Faucon G; Aupetit JF; Gerentes-Chassagne I; Loufoua-Moundanga J; Larbre JP; Timour Q
Bull Acad Natl Med; 1991 Feb; 175(2):217-24; discussion 224-5. PubMed ID: 1907520
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effects of haemodynamic stabilisation and beta blockade on ventricular fibrillation threshold in coronary artery ligated pigs.
Muller CA; Kralios AC
Cardiovasc Res; 1993 Feb; 27(2):274-8. PubMed ID: 8097133
[TBL] [Abstract][Full Text] [Related]
36. Calcium antagonists, ventricular arrhythmias, and sudden cardiac death: a major challenge for the future.
Opie LH
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S81-6. PubMed ID: 1725011
[TBL] [Abstract][Full Text] [Related]
37. Treating ischemic left ventricular dysfunction with hypertonic saline administered after coronary occlusion in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Kirby RR; Lobato EB
J Cardiothorac Vasc Anesth; 2007 Jun; 21(3):400-5. PubMed ID: 17544894
[TBL] [Abstract][Full Text] [Related]
38. Ventricular fibrillation during acute coronary occlusion is related to the dilation of the ischemic region.
Barrabés JA; Garcia-Dorado D; Padilla F; Agulló L; Trobo L; Carballo J; Soler-Soler J
Basic Res Cardiol; 2002 Nov; 97(6):445-51. PubMed ID: 12395206
[TBL] [Abstract][Full Text] [Related]
39. Haemodynamic impact of the left ventricular pacing site during graded ischaemia in an open-chest pig model.
Bordachar P; Labrousse L; Thambo JB; Reant P; Lafitte S; O'Neill MD; Jais P; Haissaguerre M; Clementy J; Dos Santos P
Europace; 2008 Feb; 10(2):242-8. PubMed ID: 18256130
[TBL] [Abstract][Full Text] [Related]
40. Ventricular fibrillation in acute experimental myocardial ischemia: protection by magnesium sulfate.
Barros LF; Da-Luz PL; Silveira MC; Chagas AC; Pileggi F
Braz J Med Biol Res; 1988; 21(4):791-9. PubMed ID: 3240378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]